Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The Nordic and Northern European region is widely regarded as a very attractive location to run clinical studies. However, like other western European countries, clinical site saturation is becoming an important issue in this region as the number of studies increase, as well as their complexity. Nordic and Northern European countries must maintain their competitive edge in contrast to other emerging clinical regions with larger, treatment naive patient populations.

 

Today in Biotechnology...keeping you current

PR distribution service for the biotech industry
b3c newswire, 12/07/09

Safety First in Biotech Development
BioPharm, 12/03/09

Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09

Today in Research & Development...keeping you current

Cerner Enters R&D Pact with University
HealthDataManagement, 12/08/09

Report: Acquisition Activity Down
HealthDataManagement, 12/08/09

Takeda to Continue Strategic Expansion with Operations in Brazil
Takeda Pharmaceuticals North America, 12/08/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address